High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$19.7M
$19,738,855
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$19,738,855MEGAx13
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $19,738,855MEGAx13 | S | Form 4 |